Developing mechanisms to support coordinated collaboration and supporting basic science to identify new drug targets are some of Africa's R&D priorities for COVID-19 listed in this document. The primary priorities were identified from a webinar attended by 275 scientists and a survey of 844 respondents.

Further information can be found at: